Suppr超能文献

离子强度、肌动蛋白状态和钙调蛋白结构大小对钙调蛋白结合位点中肌动蛋白单体数量的影响。

Influence of ionic strength, actin state, and caldesmon construct size on the number of actin monomers in a caldesmon binding site.

作者信息

Fredricksen Scott, Cai Anmei, Gafurov Boris, Resetar Andrea, Chalovich Joseph M

机构信息

Department of Biochemistry and Molecular Biology, The Brody School of Medicine at East Carolina University, 600 Moye Boulevard, Greenville, North Carolina 27858-4354, USA.

出版信息

Biochemistry. 2003 May 27;42(20):6136-48. doi: 10.1021/bi0274017.

Abstract

There is no consensus on the mechanism of inhibition of actin-myosin ATPase activity by caldesmon. Various models are based on different assumptions for the number of actin monomers that constitute a caldesmon binding site. Differences in binding behavior may be due to variations in the assay, the range of caldesmon concentrations, the type of caldesmon, and the method of data analysis used. We have evaluated these factors by measuring binding in the presence and absence of tropomyosin with both intact caldesmon and a recombinant 35 kDa actin binding fragment and with actin initially in the polymerized state or monomeric state. In all cases caldesmon binding could be simulated with a model having one class of binding sites. However, the number of actin monomers constituting a site was variable. Binding to F-actin at 165 mM ionic strength was best described with 7 actin monomers per site. When caldesmon bound to actin during the polymerization of G-actin, the size of the binding site was 3. Binding of the expressed truncated fragment, Cad35, could be described with 3 monomers per site. A simple interpretation of the data is that caldesmon binds tightly to 2-3 actin monomers. Additional parts of caldesmon bind less tightly to actin, causing caldesmon to cover approximately 7 actin monomers. The appendix contains an analysis of several binding curves with multiple binding site models. There is no compelling evidence for two classes of binding sites.

摘要

关于钙调蛋白抑制肌动蛋白 - 肌球蛋白ATP酶活性的机制尚无共识。各种模型基于对构成钙调蛋白结合位点的肌动蛋白单体数量的不同假设。结合行为的差异可能归因于测定方法、钙调蛋白浓度范围、钙调蛋白类型以及所使用的数据分析方法的变化。我们通过在有无原肌球蛋白存在的情况下,使用完整的钙调蛋白和重组的35 kDa肌动蛋白结合片段,并使肌动蛋白最初处于聚合状态或单体状态来测量结合,从而评估了这些因素。在所有情况下,钙调蛋白的结合都可以用具有一类结合位点的模型来模拟。然而,构成一个位点的肌动蛋白单体数量是可变的。在165 mM离子强度下与F - 肌动蛋白的结合,每个位点用7个肌动蛋白单体来描述最为合适。当钙调蛋白在G - 肌动蛋白聚合过程中与肌动蛋白结合时,结合位点的大小为3。表达的截短片段Cad35的结合,每个位点可用3个单体来描述。对这些数据的一个简单解释是,钙调蛋白紧密结合2 - 3个肌动蛋白单体。钙调蛋白的其他部分与肌动蛋白的结合较松,使得钙调蛋白覆盖大约7个肌动蛋白单体。附录包含了对多个结合位点模型的几条结合曲线的分析。没有令人信服的证据表明存在两类结合位点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验